Merck Shows Takeover Interest in Personalis
Personalis shares rose approximately 4% premarket after reports indicated Merck and two other companies have shown takeover interest. The biotech firm is reportedly exploring a potential sale.
More World news
- Marvell Technology Appoints Three Independent Directors Prior to Proposed Lumentum Acquisition
- M-tron Industries Reports Q3 2026 GAAP EPS Miss Amid Low Revenue
- Nexxen International Reports Q3 Earnings Beat with Revenue Growth and Increased EBITDA
- Brookfield Corporation Announces Quarterly Dividend of $0.07 Per Share
- Upwork Expands Restructuring Plan to Reduce Workforce by 37%
- Deswell Industries Reports First-Half Revenue of $33.02 Million Amid Segment Shifts
- Avicanna Reports Q3 Results with Positive Adjusted EBITDA and Reduced Operating Losses
- Bridgemarq Real Estate Services Announces Monthly Dividend of CAD 0.0125 per Share
- Natus Medical Expands Global Clinical Collaboration via New EMG and EEG Advisory Boards
- CoreWeave Reports Strong Third-Quarter Results Driven by AI Demand